Drug Self-administration Markets to 2020 - Siouxland News - KMEG 14 and FOX 44

Drug Self-administration Markets to 2020

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, February 14, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/477x2k/drug) have announced the addition of the "Drug Self-administration Markets to 2020" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Therapeutic Indications, Product Strategies, Markets and Forecasts

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration. 

Highlights

  • Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration
  • Charts product data, market share, and forecasts to 2020
  • Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered: 

Executive Summary

Drug Market Dynamics

Evolving Drug Development and Market Factors
Managed Care and Prescribing Trends
Drug Self-Administration Demand Factors
Shifting Patient Demographics
Chronic Disease and Self-administration
Biological Drugs Proliferating
Delivery Device Technology & Evolving

Drug Self-Administration Product Segments and Market Drivers

Injectable Drug Self-Administration

Market Sector Dynamics
The Shift to Prefilled Devices
Device Selection Factors
Market Segmentation & Cost
Product Features & Ease of Use
Custom Device Designs & Branding
Prefilled Syringes (PFS)
Glass PFS
Plastic PFS
Prospects for Autoinjectors
Key PFS Therapeutic Segments
The PFS Supply Chain
PFS Supplier Profiles
Pen Injectors
Reusable Pens
Disposable Pens
Key Pen Injector Therapeutic Segments
The Top Ten Pen Injector Drug Products
Five Segments Driving Pen Injector Growth
Pen Injector Company Profiles
Needle-free Injectors (NFI)
Reusable NFI
Disposable
Competitive NFI Therapeutic Segments
Needle-free Company Profiles

Inhaled Drug Self-Administration Products

Market Sector Dynamics
The Upper Respiratory Market
Established Therapeutic Targets
Dual Drug Inhalers
The Systemic/Deep Lung Market
Established Markets
Emerging Therapies
Inhaler Technology and Market Prospects
Inhaler Product Segments
Dry Powder Inhalers
Device Design Factors
Powder Technology
Packaging Issues
DPI Device Company Profiles
Metered Dose Inhalers
Manual Devices
Breathe Actuated Designs
MDI Device Company Profiles
Nebulizers
Established Nebulizer Therapies
Evolving Nebulizer Technology
Nebulizer Device Company Profiles
Performance Factors
Bioavailability
Dose Reproducibility
Active Compound Stability

Transdermal Drug Self-Administration

Market Sector Dynamics
Traditional Patch Markets
Emerging Markets
Transdermal Patch Market Drivers
Prescription Patch Design & Technology
Passive Patch Architecture
Passive Transdermal Patch Design
Passive Patch Construction
Active Transport Patch Technologies
Iontophoresis
Electroporation
Microporation
Mechanical Arrays
Radio Frequency
Thermal/Heat
Ultrasound
Prescription Patch Development Factors
Key Transdermal Therapeutic Markets
Transdermal Product Company Profiles

Drug Self-Administration - Therapeutic Sector Analysis & Forecasts

ADHD
Anticoagulants
Arthritis
Asthma/COPD
Cardiovascular
Contraception
Cystic Fibrosis
Diabetes
Hematopoietics
Hepatitis
Hormone Therapy/Replacement
Multiple Sclerosis
Neurology
Osteoporosis
Pain Management
Psoriasis
Sexual Health

Company Profiles 

For more information visit http://www.researchandmarkets.com/research/477x2k/drug

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

Siouxland News
100 Gold Circle
Dakota Dunes, SD 57049

Main Phone: 712-277-3554
Main Fax: 712-255-5250
Email: webmaster@siouxlandnews.com

Powered by WorldNow
All content © Copyright 2000 - 2009 WorldNow and Sinclair Communications, LLC. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.